EMA: First vaccine to protect adults from Chikungunya

EMA has recommended granting a marketing authorisation in the European Union (EU) for Ixchiq, the first vaccine in the EU to protect adults 18 years and older against ChikungunyaIt is given as a single dose.

Chikungunya (also called CHIK fever) is a viral disease caused by Chikungunya virus (CHIKV), a virus transmitted to humans by infected mosquitoes (primarily Aedes aegypti and Aedes albopictus).

Leave a Comment

Your email address will not be published. Required fields are marked *